tiprankstipranks
Trending News
More News >
OptimizeRx Corporation (OPRX)
NASDAQ:OPRX
US Market

OptimizeRx (OPRX) Financial Statements

Compare
579 Followers

OptimizeRx Financial Overview

OptimizeRx's market cap is currently $120.64M. The company's EPS TTM is $0.51; its P/E ratio is 44.33; OptimizeRx is scheduled to report earnings on March 5, 2026, and the estimated EPS forecast is
lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 109.43M$ 92.13M$ 71.52M$ 62.45M$ 61.29M
Gross Profit$ 69.27M$ 59.38M$ 42.90M$ 38.97M$ 35.64M
Operating Income$ 12.06M$ -13.71M$ -26.40M$ -12.29M$ 361.10K
EBITDA$ 16.39M$ -8.90M$ -21.31M$ -9.42M$ 2.33M
Net Income$ 5.13M$ -20.11M$ -17.57M$ -11.44M$ 378.08K
Balance Sheet
Cash & Short-Term Investments$ 23.36M$ 13.38M$ 13.85M$ 74.14M$ 84.68M
Total Assets$ 176.92M$ 171.17M$ 183.37M$ 134.65M$ 140.99M
Total Debt$ 26.10M$ 33.19M$ 36.82M$ 234.43K$ 327.71K
Net Debt$ 2.74M$ 19.81M$ 22.97M$ -17.97M$ -84.35M
Total Liabilities$ 48.62M$ 54.17M$ 56.82M$ 8.54M$ 9.61M
Stockholders' Equity$ 128.29M$ 117.00M$ 126.55M$ 126.11M$ 131.38M
Cash Flow
Free Cash Flow$ 18.66M$ 4.78M$ -8.11M$ 10.41M$ 240.04K
Operating Cash Flow$ 18.71M$ 4.89M$ -7.24M$ 10.65M$ 726.04K
Investing Cash Flow$ 68.00K$ -450.00K$ -25.34M$ -58.18M$ -486.00K
Financing Cash Flow$ -8.80M$ -4.91M$ 28.22M$ -18.95M$ 73.92M
Currency in USD

OptimizeRx Earnings and Revenue History

OptimizeRx Debt to Assets

OptimizeRx Cash Flow

OptimizeRx Forecast EPS vs Actual EPS